JOSEPH RONALD ERRICO
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- TEMECULA, CA
- NPI
- 1225085731
- Received
- $477,149 in 123 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 23 | $2,362 |
| 2024 | General payment | 19 | $9,439 |
| 2023 | General payment | 25 | $30,985 |
| 2022 | General payment | 24 | $68,717 |
| 2021 | General payment | 20 | $89,469 |
| 2020 | General payment | 8 | $107,909 |
| 2019 | General payment | 4 | $168,264 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Stryker Corporation | 25 | $472,714 | 2019–2025 |
| Otsuka America Pharmaceutical, Inc. | 34 | $886 | 2020–2024 |
| Neurocrine BioSciences, Inc. | 9 | $622 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 14 | $575 | 2022–2025 |
| Teva Pharmaceuticals USA, Inc. | 13 | $571 | 2022–2025 |
| E.R. Squibb & Sons, L.L.C. | 8 | $405 | 2025 |
| ABBVIE INC. | 5 | $299 | 2022–2024 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $287 | 2023–2025 |
| Axsome Therapeutics, Inc. | 4 | $269 | 2023–2024 |
| Sunovion Pharmaceuticals Inc. | 4 | $259 | 2019–2021 |
| Alkermes, Inc. | 3 | $257 | 2019–2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Royalty or License | 25 | $472,714 |
| Food and Beverage | 98 | $4,434 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-16 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-13 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-13 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-11-03 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-15 | E.R. Squibb & Sons, L.L.C. | $126 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-11 | E.R. Squibb & Sons, L.L.C. | $36 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-04 | Janssen Pharmaceuticals, Inc | $9 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-08-06 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-07-21 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-14 | E.R. Squibb & Sons, L.L.C. | $31 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-09 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-27 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-19 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-14 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-08 | E.R. Squibb & Sons, L.L.C. | $4 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-18 | Janssen Pharmaceuticals, Inc | $145 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-31 | Stryker Corporation | $1,250 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2025 | |
| 2025-01-28 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-01-21 | Neurocrine BioSciences, Inc. | $139 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-21 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-21 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2024-11-21 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-11-19 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-18 | Teva Pharmaceuticals USA, Inc. | $99 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-06-25 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-14 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-05-08 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-05-03 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-05-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-02 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-04-04 | Alkermes, Inc. | $116 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-03-14 | Teva Pharmaceuticals USA, Inc. | $6 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-03-11 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-03-08 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-02-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-29 | Stryker Corporation | $7,274 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2024 | |
| 2024-01-29 | Stryker Corporation | $1,464 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2024 | |
| 2024-01-22 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-01-11 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-01-09 | Axsome Therapeutics, Inc. | $110 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2023-11-15 | Otsuka America Pharmaceutical, Inc. | $122 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-30 | Stryker Corporation | $7,001 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-10-30 | Stryker Corporation | $1,187 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-07-31 | Stryker Corporation | $7,079 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-07-31 | Stryker Corporation | $1,236 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-07-18 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-07-14 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-12 | Teva Pharmaceuticals USA, Inc. | $78 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-07-11 | Axsome Therapeutics, Inc. | $116 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-11 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-07 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2023 | |
| 2023-06-15 | Stryker Corporation | $2,018 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-05-16 | Janssen Pharmaceuticals, Inc | $29 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-15 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-05-09 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-05 | Teva Pharmaceuticals USA, Inc. | $27 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-05-04 | Neurocrine BioSciences, Inc. | $33 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-26 | ABBVIE INC. | $117 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-14 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-03-02 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-01-27 | Stryker Corporation | $11,596 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2023 | |
| 2023-01-13 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-04 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2022-11-16 | Otsuka America Pharmaceutical, Inc. | $3 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-11-15 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-10-27 | Stryker Corporation | $12,121 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2022 | |
| 2022-09-20 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-09-20 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-09-09 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-09-07 | Janssen Pharmaceuticals, Inc | $101 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-07-28 | Stryker Corporation | $17,259 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2022 | |
| 2022-07-26 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-07-13 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-07-11 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-06-02 | Neurocrine BioSciences, Inc. | $118 | Food and Beverage | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-05-11 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-11 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-05-11 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-05-11 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-04-29 | Stryker Corporation | $17,573 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2022 | |
| 2022-03-17 | Janssen Pharmaceuticals, Inc | $109 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-03-09 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-03-02 | Teva Pharmaceuticals USA, Inc. | $125 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-02-04 | Stryker Corporation | $20,742 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2022 | |
| 2022-02-02 | Otsuka America Pharmaceutical, Inc. | $118 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-01-26 | Neurocrine BioSciences, Inc. | $123 | Food and Beverage | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-01-25 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2021-11-30 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-11-30 | Otsuka America Pharmaceutical, Inc. | $2 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-11-18 | Sunovion Pharmaceuticals Inc. | $7 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-11-17 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-10-28 | Stryker Corporation | $17,038 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2021 | |
| 2021-09-24 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-09-10 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-09-02 | Neurocrine BioSciences, Inc. | $126 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-09-01 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-07-30 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-07-29 | Stryker Corporation | $19,628 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2021 | |
| 2021-07-29 | Stryker Corporation | $19,628 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2021 | |
| 2021-07-29 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-07-29 | Sunovion Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-07-09 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-05-28 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-05-28 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-05-20 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-04-29 | Stryker Corporation | $12,998 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2021 | |
| 2021-02-01 | Stryker Corporation | $19,834 | Royalty or License | Cash or cash equivalent | XIA 3 Device, THORACOLUMBAR | 2021 | |
| 2020-11-10 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2020 | |
| 2020-10-29 | Stryker Corporation | $23,840 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2020-07-30 | Stryker Corporation | $19,386 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2020-07-22 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2020 | |
| 2020-04-28 | Stryker Corporation | $22,270 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2020-04-28 | Stryker Corporation | $3,548 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2020-02-03 | Stryker Corporation | $5,349 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2020-01-27 | Stryker Corporation | $33,483 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2020 | |
| 2019-12-31 | Stryker Corporation | $167,899 | Royalty or License | Cash or cash equivalent | XIA Device, THORACOLUMBAR | 2019 | |
| 2019-05-02 | Sunovion Pharmaceuticals Inc. | $119 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2019 | |
| 2019-02-07 | Alkermes, Inc. | $123 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2019 | |
| 2019-01-10 | Sunovion Pharmaceuticals Inc. | $121 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Temecula, CA, county Riverside County, CA, state California; placed by its city name.
| Measure | Place (city or town) Temecula, CA | County Riverside County, CA | State California |
|---|---|---|---|
| Population B01003 | 111,167 | 2,478,600 | 39,287,377 |
| Population, 2020 census P1 | 110,003 | 2,418,185 | 39,538,223 |
| Median age B01002 | 36.7 | 37.0 | 37.9 |
| Under 18 B01001 | 26.8% | 24.1% | 22.0% |
| 65 and over B01001 | 12.7% | 15.4% | 15.7% |
| Households B11001 | 36,536 | 775,335 | 13,548,091 |
| Foreign born B05002 | 15.9% | 21.9% | 27.0% |
| Median household income B19013 | $121,063 | $93,074 | $99,122 |
| Median family income B19113 | $130,015 | $103,984 | $113,346 |
| Per capita income B19301 | $47,086 | $38,317 | $49,513 |
| Poverty rate B17001 | 7.3% | 10.6% | 12.0% |
| Unemployment rate B23025 | 5.7% | 6.5% | 6.6% |
| Civilian labor force B23025 | 55,497 | 1,191,323 | 20,068,466 |
| Mean commute (minutes) B08013 | 36.3 | 33.8 | 28.7 |
| Bachelor's degree or higher B15003 | 38.8% | 25.6% | 37.1% |
| Housing units B25001 | 37,813 | 869,414 | 14,644,735 |
| Owner-occupied B25003 | 68.0% | 69.1% | 55.9% |
| Renters B25003 | 32.0% | 30.9% | 44.1% |
| Median home value B25077 | $679,700 | $557,300 | $734,700 |
| Median gross rent B25064 | $2,347 | $1,901 | $2,036 |
| White, not Hispanic B03002 | 48.4% | 31.0% | 33.8% |
| Black B03002 | 4.7% | 6.0% | 5.2% |
| Hispanic or Latino B03002 | 29.0% | 51.3% | 40.2% |
| Asian B03002 | 10.3% | 6.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.3% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Temecula, CA.
Comments